245298 people have viewed this drug in the last 60 days
Updated 2024-10-04
| Last Update | 2023-04-09 |
| Register Year | 2023 |
| Product Type | Human |
| Drug Type | Biological |
| Scientific Name | HUMAN C1-ESTERASE INHIBITOR |
| Trade Name | Cinryze |
| Strength Unit | IU |
| Pharmaceutical Form | Powder and solvent for solution for injection |
| Administration Route | Intravenous use |
| Atc Code1 | QB06AC01 |
| Atc Code2 | |
| Size | 0 |
| Size Unit | |
| Package Types | Vial |
| Package Size | 2 |
| Legal Status | Prescription |
| Product Control | Uncontrolled |
| Distribute Area | Hospital |
| Public price | $5249.9 |
| Shelf Life | 24 Months |
| Marketing Company | Shire Services BVBA |
| Marketing Country | Belgium |
| Manufacture Name | TAKEDA MANUFACTURING AUSTRIA AG |
| Manufacture Country | Austria |
| Secondry package manufacture | |
| Main Agent | Abdulrehman Algosaibi G.T.C. |
| Secosnd Agent | |
| Third Agent | |
| Visits | 245298 |
Do not forget, after purchasing the medicine, help us determine the price more accurately, press the button below and adjust the price directly
| Name | Price | Visits | Updated |
|---|---|---|---|
| Cinryze | $5249.9 | 245298 visits | 2023-04-09 |